                         SEQUENCE LISTING

<110>  VITO NV
       Katholieke Universiteit Leuven
       INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE 
       (INSERM)
       APHP - Assistance Publique - Hpitaux Paris
       University hospital Center of Limoges
       Medizinische Hochschule Hannover
 
<120>  Biomarkers for typing allograft recipients

<130>  P117691PC00

<140>  PCT/EP2018/097044
<141>  2018-12-27

<150>  EP 17306944.4
<151>  2017-12-27

<160>  22    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  1

Glu Gln Leu Gln Asp Met Gly Leu Val Asp Leu Phe Ser Pro Glu Lys 
1               5                   10                  15      


<210>  2
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  2

Val Ala Glu Gly Thr Gln Val Leu Glu Leu Pro Phe Lys 
1               5                   10              


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  3

Leu Ser Ile Thr Gly Thr Tyr Asp Leu Lys 
1               5                   10  


<210>  4
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  4

Ser Val Leu Gly Gln Leu Gly Ile Thr Lys 
1               5                   10  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  5

Asp Ala Ser Gly Val Thr Phe Thr Trp Thr Pro Ser Ser Gly Lys 
1               5                   10                  15  


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  6

Thr Phe Thr Cys Thr Ala Ala Tyr Pro Glu Ser Lys 
1               5                   10          


<210>  7
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  7

Cys Ser Thr Ser Ser Leu Leu Glu Ala Cys Thr Phe Arg 
1               5                   10              


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  8

Asp Ser Gly Phe Gln Met Asn Gln Leu Arg 
1               5                   10  


<210>  9
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  9

Ala Thr Trp Ser Gly Ala Val Leu Ala Gly Arg 
1               5                   10      


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  10

Cys Glu Gly Pro Ile Pro Asp Val Thr Phe Glu Leu Leu Arg 
1               5                   10                  


<210>  11
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  11

Ala Glu Ser Pro Glu Val Cys Phe Asn Glu Glu Ser Pro Lys 
1               5                   10                  


<210>  12
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  12

Phe Thr Asp Ser Glu Asn Val Cys Gln Glu Arg 
1               5                   10      


<210>  13
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  13

Asp Leu Ala Thr Val Tyr Val Asp Val Leu Lys 
1               5                   10      


<210>  14
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  14

Asp Tyr Val Ser Gln Phe Glu Gly Ser Ala Leu Gly Lys 
1               5                   10              


<210>  15
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  15

Ile Ser Ala Ser Ala Glu Glu Leu Arg 
1               5                   


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  16

Ser Leu Ala Glu Leu Gly Gly His Leu Asp Gln Gln Val Glu Glu Phe 
1               5                   10                  15      


Arg 
    


<210>  17
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  17

Thr Thr Pro Pro Val Leu Asp Ser Asp Gly Ser Phe Phe Leu Tyr Ser 
1               5                   10                  15      


Arg 
    


<210>  18
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  18

Tyr Gly Pro Pro Cys Pro Ser Cys Pro Ala Pro Glu Phe Leu Gly Gly 
1               5                   10                  15      


Pro Ser Val Phe Leu Phe Pro Pro Lys Pro Lys 
            20                  25          


<210>  19
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  19

Ala Leu Gly His Leu Asp Leu Ser Gly Asn Arg 
1               5                   10      


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  20

Asp Leu Leu Leu Pro Gln Pro Asp Leu Arg 
1               5                   10  


<210>  21
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  21

Ala Asp Gly Glu Ser Cys Ser Ala Ser Met Met Tyr Gln Glu Gly Lys 
1               5                   10                  15      


<210>  22
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide used for training the SVM model

<400>  22

Ile Glu Asp Gly Phe Ser Leu Lys 
1               5               


